SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16814664
Source:
http://linkedlifedata.com/resource/pubmed/id/16814664
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0014822
,
umls-concept:C0027051
,
umls-concept:C0027686
,
umls-concept:C0242698
,
umls-concept:C0332161
,
umls-concept:C1280551
,
umls-concept:C2349975
,
umls-concept:C2919051
pubmed:issue
1
pubmed:dateCreated
2006-7-3
pubmed:abstractText
We investigated the effects of erythropoietin (EPO) on neovascularization and cardiac function after myocardial infarction (MI).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16814664-16814665
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34
,
http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1558-3597
pubmed:author
pubmed-author:AsanumaHiroshiH
,
pubmed-author:FujitaMasashiM
,
pubmed-author:HirataAkioA
,
pubmed-author:HoriMasatsuguM
,
pubmed-author:KitakazeMasafumiM
,
pubmed-author:KomamuraKazuoK
,
pubmed-author:KoyamaHidekazuH
,
pubmed-author:MinaminoTetsuoT
,
pubmed-author:MoriHidezoH
,
pubmed-author:MyoishiMasafumiM
,
pubmed-author:OkadaKen-ichiroK
,
pubmed-author:ShinozakiYoshiroY
,
pubmed-author:ShiragaMasamichiM
,
pubmed-author:TakashimaSeijiS
,
pubmed-author:TsukamotoOsamuO
,
pubmed-author:WakenoMasakatsuM
pubmed:issnType
Electronic
pubmed:day
4
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
176-84
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16814664-Animals
,
pubmed-meshheading:16814664-Antigens, CD34
,
pubmed-meshheading:16814664-Capillaries
,
pubmed-meshheading:16814664-Coronary Circulation
,
pubmed-meshheading:16814664-Dogs
,
pubmed-meshheading:16814664-Erythropoietin
,
pubmed-meshheading:16814664-Hemodynamics
,
pubmed-meshheading:16814664-Leukocytes, Mononuclear
,
pubmed-meshheading:16814664-Myocardial Infarction
,
pubmed-meshheading:16814664-Neovascularization, Physiologic
,
pubmed-meshheading:16814664-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:16814664-Ventricular Dysfunction, Left
pubmed:year
2006
pubmed:articleTitle
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
pubmed:affiliation
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
pubmed:publicationType
Journal Article